Payor executives / provider customers treat this person as their primary product partner by default, the roadmap reflects real field signal from GTM and Engineering rather than assumptions, and Sales has ROI models and case studies, built with their input, that are actively used to close new deals. We recently raised a $126M Series C at a $3.5B valuation, led by Avenir Growth, bringing total funding to $404M with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children's, WellSpan Health, John Doerr, Rick Klausner, and others.